CYTOMED THERAPEUTICS LIMITED
GDTC·Y1R80M106·US·Common Stock·Healthcare - Biotechnology-Activist
GDTC (CYTOMED THERAPEUTICS LIMITED) is held by 2 institutional investors as of Q2 2026. Largest holders: UBS Group AG ($4,976), OSAIC HOLDINGS, INC. ($21). Net institutional sentiment: Bearish.
2
Holders
$4,997
Total Value
0% (2)
Consensus
0 buying - 2 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Jul 24, 2026 · Activists Jul 24, 2026 · Congress none
ActivistCCChoo Chee Kong24.3%Jul 24, 2026
InsiderCKChoo Chee KongBuy $150KJul 20, 2026
InsiderCKChoo Chee KongBuy $150KJul 14, 2026
Checking access…
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer